Serving hundreds of leading biopharmaceutical companies globally:

UBS
Citi
Boehringer Ingelheim
Julphar
Cantor Fitzgerald
Queensland Health

Pharmaceutical companies with the most 'Pediatric Exclusivity' drugs

This chart shows the companies which have received the most pediatric exclusivities in the past five years.

Pediatric exclusivity is granted to drug companies for conducting pediatric studies on their drugs, following a FDA request to do so.

A unique aspect of pediatric exclusivity, relative to the other FDA-granted exclusivities, is that the term of pediatric exclusivity starts when patents expire. Accordingly, unlike other regulatory exclusivities which tend to run concurrent with patents and expire before patents, pediatric exclusivity provides protection beyond the patent-protected period.

The companies with the most pediatric exclusivities are:
Back to Pharmaceutical Industry Infographics

Make Better Decisions: Try a trial or see plans & pricing